Sign in

CIK 0001404644

  • Non-accelerated filer
  • Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
980542593
Phone
+1 877-237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2018-05-07 Bridger Gary Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2017-05-08 Bridger Gary Director Grant or award · Stock Option (Right to Buy) +9,000 9,000
2016-05-09 Bridger Gary Director Grant or award · Stock Option (Right to Buy) +7,500 7,500
2015-10-31 Bridger Gary Director Other disposition −1,543,989 0
2015-03-12 Bridger Gary Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2014-03-12 Bridger Gary Director Grant or award +36,502 40,147
2014-03-12 Bridger Gary Director Returned to the company −40,147 0
2014-03-12 Bridger Gary Director Returned to the company −284,090 0
2014-03-12 Bridger Gary Director Returned to the company −189,393 0
2014-03-12 Bridger Gary Director Returned to the company −326,538 0
2014-03-12 Bridger Gary Director Returned to the company −325,035 0
2014-03-12 Bridger Gary Director Returned to the company −378,786 0
2014-03-12 Bridger Gary Director Conversion +1,543,989 1,543,989
2014-03-12 Bridger Gary Director Grant or award · Common Exchangeable Shares +36,502 $11.00 $402K 40,147
2014-03-12 Bridger Gary Director Conversion · Common Exchangeable Shares −40,147 0
2014-03-12 Bridger Gary Director Conversion · Series A-1 Exchangeable Shares −284,090 0
2014-03-12 Bridger Gary Director Conversion · Series A-1 Preferred Stock +284,090 0
2014-03-12 Bridger Gary Director Conversion · Series A-1 Preferred Stock −284,090 0
2014-03-12 Bridger Gary Director Conversion · Series A-2 Exchangeable Shares −189,393 0
2014-03-12 Bridger Gary Director Conversion · Series A-2 Preferred Stock +189,393 0

Page 1 of 2 · 31 trades